An interventional study of Nutrient Warning Label and Multiple Traffic Light label in Food Labeling, Diet, Healthy and Consumer Behavior, sponsored by Johns Hopkins Bloomberg School of Public Health. Recruiting at 3 sites in Philippines. Open to participants aged 18 Years to 59 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by Johns Hopkins Bloomberg School of Public Health · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Obesity by Johns Hopkins Bloomberg School of Public Health — 1 open to participants now, 1 under way, none of them phase 3. Obesity · Johns Hopkins Bloomberg School of Public Health.
Among the 22 studies in Obesity by Johns Hopkins Bloomberg School of Public Health, this one has the largest planned enrollment of the 19 interventional ones that give a count, is the only one that started in 2026, is one of 19 with no phase, and was the 22nd registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →1 of the 22 studies in Obesity by Johns Hopkins Bloomberg School of Public Health is open now, in 1 country.
By country, each count listing its studies:
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 18 Years to 59 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
First in 1990; this study’s year is marked. 1 started in 2026.
This study's planned enrollment of 2,105 is above the median of 67 across 9,043 interventional studies indexed under Obesity.
Median enrollment 136 across the 19 interventional studies, 155 across the 3 observational. Of the 21 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
Johns Hopkins Bloomberg School of Public Health is the lead sponsor of 371 studies on the registry; 41 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.
1 of the studies in Obesity by Johns Hopkins Bloomberg School of Public Health that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07950345Johns Hopkins Bloomberg School of Public HealthEffect of Front-of-Package Labels on Intent to Purchase Packaged Foods in the Philippines | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 22 studies in Obesity by Johns Hopkins Bloomberg School of Public Health, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The Philippines is considering a mandatory front-of-package label (FoPL) for packaged foods. This randomized controlled trial will test which label design best helps consumers avoid products high in sugar, sodium, or saturated fat. Adults who buy packaged foods will be approached outside supermarkets and other food retailers in three locations: the City of Manila, Iloilo City, and the Municipality of San Jose, Dinagat Islands. After consent, each participant will be randomly assigned to one of five groups and will view mock packaged food products on a tablet: no label (control), a Nutrient Warning Label, a Multiple Traffic Light label, a Health Star Rating, or a Nutri-Grade style label. The main outcome is how likely participants say the participant is to buy products that contain nutrients of concern in excess. The study will also measure whether participants can correctly identify which nutrients are in excess, which of two similar products the participant would buy, and which product the participant thinks is healthier. Results will inform FoPL policy in the Philippines.
This is a five-arm, parallel-group, individually randomized trial with a single study visit of about 25 minutes. Trained research assistants recruit participants using street-intercept methods outside food retailers, screen for eligibility, and obtain written informed consent. Participants are randomized 1:1:1:1:1 in REDCap, stratified by study site, using an allocation table generated by an independent statistician; the enumerator does not know the allocation sequence in advance.
Within the assigned arm, participants complete: (1) single-product tasks, in which the participant views one mock product at a time (product order randomized), rate the intent to purchase on a 7-point scale, and indicate whether the product contains sugar, sodium, saturated fat, or protein in excess (protein is a distractor and is never in excess); (2) paired-product comparison tasks, in which, for three pairs of similar products showing different versions of the same label system, the participant's choose which product the participant would buy, which is healthier, and which the participant would be more worried about a child consuming; and (3) label acceptability questions, a label comparison task, and demographic questions. The Pan American Health Organization (PAHO) Nutrient Profile Model is used as an independent standard to classify products as containing sugar, sodium, or saturated fat in excess.
Sample size: 2,105 participants (approximately 701 per site; 421 per arm). This provides 80% power to detect a 0.36-point difference in mean intent to purchase (SD 1.5) for each label versus no label (Bonferroni alpha = 0.0125) and for pairwise comparisons among effective labels (alpha = 0.0083).
Primary analysis: a linear model of each participant's mean purchase-intent score across four products, with treatment arm as a fixed effect and no label as the reference category (four primary contrasts), adjusting for pre-specified baseline covariates that are imbalanced across arms. Multiplicity is controlled using the Hochberg step-down procedure. If any label is effective compared with no label, effective labels are compared pairwise (up to six contrasts). Statisticians are blinded to arm assignment for the primary outcome analysis.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
This study's planned enrollment of 2,105 is above the median of 67 across 9,043 interventional studies indexed under Obesity.
Browse Obesity studies →Johns Hopkins Bloomberg School of Public Health is the lead sponsor of 371 studies on the registry; 41 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.
Compared within Obesity, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Consumer Behavior. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants view mock packaged food products without any front-of-package label.
Mock packaged food products display black octagonal warning labels for each nutrient (sugar, sodium, saturated fat) present in excess.
Behavioral: Nutrient Warning Label
Mock packaged food products display a Multiple Traffic Light label with red, amber, or green color coding of sugar, sodium, and saturated fat levels.
Behavioral: Multiple Traffic Light label
Mock packaged food products display a Health Star Rating summary score (0.5 to 5 stars).
Behavioral: Health Star Rating label
Mock packaged food products display a Nutri-Grade style letter-grade label.
Behavioral: Nutri-Grade style label
Front-of-package warning symbols flagging each nutrient of concern (sugar, sodium, saturated fat) that exceeds the label's nutrient profile threshold, applied to mock packaged food images shown on a tablet during a single study visit.
Also known as: NWL
Front-of-package label showing levels of sugar, sodium, and saturated fat color-coded red, amber, or green, applied to mock packaged food images shown on a tablet during a single study visit.
Also known as: MTL
Front-of-package summary rating from 0.5 to 5 stars based on an underlying nutrient profile algorithm, applied to mock packaged food images shown on a tablet during a single study visit.
Also known as: HSR
Front-of-package letter-grade summary label (Nutri-Grade style), applied to mock packaged food images shown on a tablet during a single study visit.
Also known as: NG
Mean Self-Reported Intent to Purchase Products Containing Nutrients of Concern in Excess
After viewing each of four mock packaged products containing sugar, sodium, and/or saturated fat in excess (per the PAHO Nutrient Profile Model), participants answer: "Imagine you were looking to buy \[product\]. Would you buy this product for yourself or your family?" on a fully labeled 7-point scale (1 = I would certainly not buy this product; 4 = Neutral; 7 = I would definitely buy this product). The outcome is the participant's mean score across the four products (range 1-7; higher scores indicate greater intent to purchase). Each front-of-package label arm is compared with the no-label control.
Time frame: During the single study visit (Day 1, approximately 25 minutes)
Accuracy in Identifying Nutrients of Concern Present in Excess
For each single-product task, participants report whether the product contains sugar, sodium, saturated fat, and protein in excess (Yes / No / I don't know). Reported as the proportion of correct identifications (sensitivity and overall accuracy) per nutrient and pooled across products, compared between each label arm and no label and among effective labels. "I don't know" is counted as incorrect. Protein is never in excess; the false-positive rate for protein is also reported.
Time frame: During the single study visit (Day 1)
Selection of the Healthier Product for Purchase in Paired Product Comparisons
For each of three pairs of similar products showing different versions of the assigned label system (e.g., fewer vs. more warnings), participants choose which product the participant would buy (Product A / Product B / Either / Neither). Outcome: selection of the healthier product (1) vs. any other response (0), analyzed with mixed-effects logistic regression (adjusted odds ratio vs. no label).
Time frame: During the single study visit (Day 1)
Correct Identification of the Healthier Product in Paired Product Comparisons
For each of three product pairs, participants choose which product is healthier (Product A / Product B / I don't know). Outcome: correct choice (1) vs. incorrect choice or "I don't know" (0), analyzed with mixed-effects logistic regression (adjusted odds ratio vs. no label).
Time frame: During the single study visit (Day 1)
Concern About Child Consumption in Paired Product Comparisons (proportion of participants selecting the less healthful product)
For each of three product pairs, participants choose which product the participant would be more worried about letting a child consume (Product A / Product B / I don't know). Reported as the proportion selecting the less healthful product, by arm.
Time frame: During the single study visit (Day 1)
Plan to share: No — Under the Institutional Review Board (IRB) approved data management plan, individual participant data will not be shared with investigators outside the study team.
No publications or documents are linked to this record.
Started Nov 2026 (actual). Primary completion is estimated for Dec 2026, 1 month after the start.
Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 1 month is below that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Johns Hopkins Bloomberg School of Public Health →